Predictors for remission in rheumatoid arthritis patients: A systematic review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kuuliala A, 2005, Serum soluble interleukin‐2 receptor predicts early remission in patients with recent‐onset rheumatoid arthritis treated with a single disease‐modifying antirheumatic drug, Clin Exp Rheumatol, 23, 243
Vazquez I, 2007, Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical setting, Clin Exp Rheumatol, 25, 231
James HM, 2008, Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis, J Rheumatol, 35, 562
Mancarella L, 2007, Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor‐α blockers: the GISEA study, J Rheumatol, 34, 1670
Liang GC, 2005, Current tumor necrosis factor‐α inhibitor use is associated with a higher probability of remissions in patients with rheumatoid arthritis, J Rheumatol, 32, 1662
Sokka T, 2009, Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST‐RA study, Arthritis Res Ther, 11, R7
Aletaha D, 2006, Remission of rheumatoid arthritis: should we care about definitions?, Clin Exp Rheumatol, S45
1993, Outcome measures in rheumatoid arthritis clinical trials, J Rheumatol, 20, 526